Elixirr International (ELIX) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
22 Jun, 2026Strategic response to operational challenges
Production was suspended on 28 February 2026 due to security concerns, after a strong start to the year with gross production exceeding 44,000 bopd.
Swift cost reductions were implemented, focusing only on safety-critical or strategic capital projects, such as PF-2 water handling.
Operating and staff costs were minimized, with flexibility to reduce further if needed.
Maintained full restart capacity, ensuring readiness to resume production quickly.
Financial resilience and balance sheet management
Maintained a robust balance sheet with $66 million in cash as of 18 June 2026.
Ongoing recovery of export sales receivables up to February 2026 supported liquidity.
Paid a $12.5 million dividend in April 2026, with future capital allocation to be reviewed after oil sales restart.
Progress towards sustainable exports and future growth
Actively working with regional and federal stakeholders to secure conditions for safe production restart.
Making good progress towards sustainable export sales at international prices, with contractual cost reviews nearing completion.
Anticipates reconciliation to full PSC entitlement at international prices and is discussing extensions to export agreements.
Advancing projects for future growth, including water handling facilities and a revised field development plan.
Latest events from Elixirr International
- Record AI-driven growth, strong margins, and global expansion underpin robust FY 25 results.ELIX
H2 202524 Apr 2026 - Revenue, EBITDA, and dividend growth drive record performance and FTSE 250 ambitions.ELIX
H2 2025 TU22 Jan 2026 - Record H1 2024 revenue and EBITDA growth, strong cash flow, and positive FY24 outlook.ELIX
H1 202419 Jan 2026 - Record FY24 growth, US expansion, and Main Market move set stage for continued outperformance.ELIX
H2 20247 Jan 2026 - 35% revenue and 42% EBITDA growth, Main Market move, and TRC deal drive strong outlook.ELIX
H1 202521 Dec 2025 - FY24 results beat expectations, with strong growth, high margins, and full debt repayment.ELIX
H2 2024 TU8 Oct 2025 - Record revenue growth and strong margins in H1 2025, with a confident outlook for FY 2025.ELIX
H1 2025 TU8 Oct 2025